Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04801498 · ClinicalTrials.gov registry record
Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 38
- Enrollment target
NCT04801498: Completed study, sponsored by University of Kansas Medical Center.
NCT04801498 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04801498 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
This pilot study is being performed to examine whether epidermal axons are altered in patients taking opioid therapy for chronic non-cancer pain, and if epidermal axonal changes predict heightened pain sensitivity.
Primary Outcome
Intraepidermal Nerve Fiber Density
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2020-12-07 |
| Est. Completion | 2024-06-25 |
What the finished NCT04801498 record still lists
NCT04801498 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04801498 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04801498 about?
NCT04801498 is a clinical study titled "Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density". This pilot study is being performed to examine whether epidermal axons are altered in patients taking opioid therapy for chronic non-cancer pain, and if epidermal axonal changes predict heightened pain sensitivity.
What is the current status of trial NCT04801498?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2020-12-07. Estimated completion is 2024-06-25.
Who is sponsoring clinical trial NCT04801498?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI